Systemic sclerosis-associated interstitial lung disease

A Perelas, RM Silver, AV Arrossi… - The Lancet respiratory …, 2020 - thelancet.com
Systemic sclerosis is an autoimmune connective tissue disease, which is characterised by
immune dysregulation and progressive fibrosis that typically affects the skin, with variable …

Interstitial lung disease in connective tissue disorders

A Fischer, R Du Bois - The lancet, 2012 - thelancet.com
Some of the most pressing challenges associated with interstitial lung disease (ILD) are how
best to define, diagnose, and treat connective tissue disease-associated ILD (CTD-ILD) …

[HTML][HTML] Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases

KR Davidson, DM Ha, MI Schwarz… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Bronchoalveolar lavage (BAL) is a commonly used procedure in the evaluation of lung
disease as it allows for sampling of the lower respiratory tract. In many circumstances, BAL …

Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis

N Maugeri, A Capobianco, P Rovere-Querini… - Science translational …, 2018 - science.org
Endothelial cell damage and platelet activation contribute to sustained vasculopathy, which
is a key clinical characteristic of systemic sclerosis (SSc), also known as scleroderma …

Pathogenesis of systemic sclerosis associated interstitial lung disease

SI Nihtyanova, CP Denton - Journal of scleroderma and …, 2020 - journals.sagepub.com
Systemic sclerosis is an autoimmune disease leading to vasculopathy and fibrosis of skin
and internal organs. Despite likely shared pathogenic mechanisms, the patterns of skin and …

Mesenchymal stromal cells for systemic sclerosis treatment

D Farge, S Loisel, P Lansiaux, K Tarte - Autoimmunity Reviews, 2021 - Elsevier
Systemic sclerosis (SSc) is a rare chronic autoimmune disease characterized by
vasculopathy, dysregulation of innate and adaptive immune responses, and progressive …

[HTML][HTML] Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients

K Schmidt, L Martinez-Gamboa, S Meier, C Witt… - Arthritis research & …, 2009 - Springer
Introduction Interstitial lung disease (ILD) is a frequent manifestation of systemic sclerosis
(SSc), and cytokines can contribute to the disease pathology. The aim of the current study …

[HTML][HTML] Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis

K Zhao, C Kong, N Shi, J Jiang, P Li - Frontiers in Immunology, 2023 - frontiersin.org
Systemic sclerosis (SSc) is an intricate systemic autoimmune disease with pathological
features such as vascular injury, immune dysregulation, and extensive fibrosis of the skin …

[HTML][HTML] Potential role of JAK inhibitors in the treatment of systemic sclerosis-associated interstitial lung disease: a narrative review from pathogenesis to real-life data

E Fiorentini, F Bonomi, S Peretti, M Orlandi, G Lepri… - Life, 2022 - mdpi.com
Background: Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is one of the
most relevant complications of SSc and the major cause of death. The pathogenesis of SSc …

Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses

A Fields, KN Potel, R Cabuhal, B Aziri, ID Stewart… - Thorax, 2023 - thorax.bmj.com
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is rare, poorly understood,
with heterogeneous characteristics resulting in difficult diagnosis. We aimed to …